This fact sheet describes a phase 4, post-licensure influenza vaccine effectiveness study that PATH and its partners are conducting in Senegal. The study seeks to better understand the extent of the influenza disease burden in tropical Africa, as well as the potential of current seasonal influenza vaccines to reduce influenza-related deaths in the developing world. Ultimately, study data could help public health officials decide how to best use influenza vaccines in Senegal and in similar tropical countries.

Corporate author(s): PATH

Publication date: May 2011

Available materials


Understanding Influenza Vaccine Effectiveness in Senegal

164 KB PDF

Hard copies are not available.


Understanding Influenza Vaccine Effectiveness in Senegal [French]

652 KB PDF

Also known as: Comprendre l’Efficacité du Vaccin Antigrippal au Sénégal

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Related regions: Africa

See also:

For more information…

Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA